UniProtKB/Swiss-Prot O95319: Variant p.Asp438His

CUGBP Elav-like family member 2
Gene: CELF2
Feedback?

Variant information Variant position:

438 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Aspartate (D) to Histidine (H) at position 438 (D438H, p.Asp438His). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and acidic (D) to medium size and polar (H) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1050942 [ dbSNP | Ensembl ]

Sequence information Variant position:

438 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

508 The length of the canonical sequence.
Location on the sequence:

EGPEGANLFIYHLPQEFGDQ D ILQMFMPFGNVISAKVFIDK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         EGPEGANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDK

Mouse                         EGPEGANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDK

Rat                           EGPEGANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDK

Chicken                       EGPEGANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDK

Xenopus laevis                EGPEGANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDK

Xenopus tropicalis            EGPEGANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDK

Zebrafish                     EGPEGANLFIYHLPQEFGDQDILQMFMPFGNVVSAKVFIDK

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 508	CUGBP Elav-like family member 2
Domain	423 – 501	RRM 3
Region	357 – 508	Necessary for RNA-binding, TNNT2 exon 5 and NMDA R1 exon 21 inclusion
Helix	436 – 443

Literature citations
Fluorescent differential display analysis of gene expression in apoptotic neuroblastoma cells.
Choi D.-K.; Ito T.; Mitsui Y.; Sakaki Y.;
Gene 223:21-31(1998)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4); VARIANT HIS-438; A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator.
Good P.J.; Chen Q.; Warner S.J.; Herring D.C.;
J. Biol. Chem. 275:28583-28592(2000)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2); TISSUE SPECIFICITY; VARIANT HIS-438;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.